Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (86)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buljevac, D.
Right arrow Articles by Hintzen, R. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buljevac, D.
Right arrow Articles by Hintzen, R. Q.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 5, 952-960, May 2002
© 2002 Guarantors of Brain

Prospective study on the relationship between infections and multiple sclerosis exacerbations

D. Buljevac1, H. Z. Flach2, W. C. J. Hop3, D. Hijdra4, J. D. Laman4, H. F. J. Savelkoul4, F. G. A. van der Meché1, P. A. van Doorn1 and R. Q. Hintzen1

1 Departments of Neurology, 2 Radiology, 3 Epidemiology and Biostatistics and 4 Immunology, Erasmus MC, Rotterdam, The Netherlands

Correspondence to: R. Q. Hintzen, Academic Hospital Rotterdam, Department of Neurology, Postbox 2040, 3000 CA Rotterdam, The Netherlands E-mail: rhintzen{at}xs4all.nl

One of the characteristics of multiple sclerosis is the unpredictable occurrence of exacerbations and remissions. These fluctuations in disease activity are related to alterations in (auto-)immune activity. Exacerbations lead to short-term morbidity, but may also influence long-term disability. This longitudinal study in 73 patients with relapsing–remitting multiple sclerosis assessed the contribution of systemic infections to the natural course of exacerbations. In addition, we analysed whether infections lead to an increase in the number of gadolinium-enhancing lesions. A total of 167 infections and 145 exacerbations were observed during 6466 patient weeks. During a predefined at-risk period (ARP) of 2 weeks before until 5 weeks after the onset of a clinical infection (predominantly upper airway infections), there was an increased risk of exacerbations (rate ratio 2.1), which is in accordance with previous studies. Exacerbations with onset during the ARP led more frequently to sustained deficit [increase of >=1 Expanded Disability Status Scale (EDSS) point or >=0.5 above EDSS 5.5 for >3 months] than exacerbations with onset outside the ARP, with a rate ratio of 3.8. Minor and major exacerbations were equally distributed between the ARP and non-ARP onset groups. ARP exacerbations were associated with significantly higher plasma levels of the inflammatory marker soluble intracellular adhesion molecule 1 than non-ARP exacerbations, indicating relatively enhanced immune activation during ARP relapses. Three serial MRI scans were performed after the onset of an infection over a 6-week period. There was no difference in the number of gadolinium-enhancing lesions between the three time points. In conclusion, exacerbations in the context of a systemic infection lead to more sustained damage than other exacerbations. There is no indication that this effect occurs through enhanced opening of the blood–brain barrier.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
H. Zhou, G. Andonegui, C. H. Y. Wong, and P. Kubes
Role of Endothelial TLR4 for Neutrophil Recruitment into Central Nervous System Microvessels in Systemic Inflammation
J. Immunol., October 15, 2009; 183(8): 5244 - 5250.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
C J Fowler, J N Panicker, M Drake, C Harris, S C W Harrison, M Kirby, M Lucas, N Macleod, J Mangnall, A North, et al.
A UK consensus on the management of the bladder in multiple sclerosis
Postgrad. Med. J., October 1, 2009; 85(1008): 552 - 559.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C J Fowler, J N Panicker, M Drake, C Harris, S C W Harrison, M Kirby, M Lucas, N Macleod, J Mangnall, A North, et al.
A UK consensus on the management of the bladder in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 470 - 477.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Serres, D. C. Anthony, Y. Jiang, K. A. Broom, S. J. Campbell, D. J. Tyler, S. I. van Kasteren, B. G. Davis, and N. R. Sibson
Systemic Inflammatory Response Reactivates Immune-Mediated Lesions in Rat Brain
J. Neurosci., April 15, 2009; 29(15): 4820 - 4828.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M Kneider, T Bergstrom, C Gustafsson, N Nenonen, C Ahlgren, S Nilsson, and O Andersen
Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS
Multiple Sclerosis, April 1, 2009; 15(4): 437 - 442.
[Abstract] [PDF]

Home page
 JEMHome page
W. Hou, H. S. Kang, and B. S. Kim
Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection
J. Exp. Med., February 16, 2009; 206(2): 313 - 328.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
C Potagas, C Mitsonis, L Watier, G Dellatolas, A Retziou, P. Mitropoulos, C Sfagos, and D Vassilopoulos
Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study
Multiple Sclerosis, November 1, 2008; 14(9): 1262 - 1268.
[Abstract] [PDF]

Home page
 BrainHome page
S. Jilek, M. Schluep, P. Meylan, F. Vingerhoets, L. Guignard, A. Monney, J. Kleeberg, G. Le Goff, G. Pantaleo, and R. A. Du Pasquier
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
Brain, July 1, 2008; 131(7): 1712 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
M. Leone, S. Bonissoni, L. Collimedaglia, F. Tesser, S. Calzoni, A. Stecco, P. Naldi, and F. Monaco
Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
Multiple Sclerosis, May 1, 2008; 14(4): 485 - 493.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
I. A. Hoppenbrouwers, F. Liu, Y. S. Aulchenko, G. C. Ebers, B. A. Oostra, C. M. van Duijn, and R. Q. Hintzen
Maternal Transmission of Multiple Sclerosis in a Dutch Population
Arch Neurol, March 1, 2008; 65(3): 345 - 348.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Millward, M. Caruso, I. L. Campbell, J. Gauldie, and T. Owens
IFN-{gamma}-Induced Chemokines Synergize with Pertussis Toxin to Promote T Cell Entry to the Central Nervous System
J. Immunol., June 15, 2007; 178(12): 8175 - 8182.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Burrer, M. J. Buchmeier, T. Wolfe, J. P.C. Ting, R. Feuer, A. Iglesias, and M. G. von Herrath
Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies
Am. J. Pathol., February 1, 2007; 170(2): 557 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
I A Hoppenbrouwers, L. P. Cortes, Y S Aulchenko, K Sintnicolaas, O Njajou, P J. Snijders, B A Oostra, C M van Duijn, and R Q Hintzen
Familial clustering of multiple sclerosis in a Dutch genetic isolate
Multiple Sclerosis, January 1, 2007; 13(1): 17 - 24.
[Abstract] [PDF]

Home page
 J Antimicrob ChemotherHome page
I. Herrmann, M. Kellert, A. Spreer, J. Gerber, H. Eiffert, M. Prinz, and R. Nau
Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice
J. Antimicrob. Chemother., January 1, 2007; 59(1): 74 - 79.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R Q Hintzen and L I van den Born
Acute zonal occult outer retinopathy and multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1373 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Zhou, B. M. Lapointe, S. R. Clark, L. Zbytnuik, and P. Kubes
A Requirement for Microglial TLR4 in Leukocyte Recruitment into Brain in Response to Lipopolysaccharide
J. Immunol., December 1, 2006; 177(11): 8103 - 8110.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Toft-Hansen, R. Buist, X.-J. Sun, A. Schellenberg, J. Peeling, and T. Owens
Metalloproteinases Control Brain Inflammation Induced by Pertussis Toxin in Mice Overexpressing the Chemokine CCL2 in the Central Nervous System
J. Immunol., November 15, 2006; 177(10): 7242 - 7249.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. H. Tran, Y.-T. Azuma, M. Chen, C. Weston, R. J. Davis, and R. A. Flavell
Inactivation of JNK1 enhances innate IL-10 production and dampens autoimmune inflammation in the brain
PNAS, September 5, 2006; 103(36): 13451 - 13456.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Correale, M. Fiol, and W. Gilmore
The risk of relapses in multiple sclerosis during systemic infections
Neurology, August 22, 2006; 67(4): 652 - 659.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
I. Herrmann, M. Kellert, H. Schmidt, A. Mildner, U. K. Hanisch, W. Bruck, M. Prinz, and R. Nau
Streptococcus pneumoniae Infection Aggravates Experimental Autoimmune Encephalomyelitis via Toll-Like Receptor 2.
Infect. Immun., August 1, 2006; 74(8): 4841 - 4848.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. Cassan, E. Piaggio, J. P. Zappulla, L. T. Mars, N. Couturier, F. Bucciarelli, S. Desbois, J. Bauer, D. Gonzalez-Dunia, and R. S. Liblau
Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells
J. Immunol., August 1, 2006; 177(3): 1552 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Liu, L. V. Kaer, A. L. Cava, M. Price, D. I. Campagnolo, M. Collins, D. A. Young, T. L. Vollmer, and F.-D. Shi
Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease
J. Immunol., May 1, 2006; 176(9): 5247 - 5254.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
J P A Samijn, P A W te Boekhorst, T Mondria, P A van Doorn, H Z Flach, F G A van der Meche, J Cornelissen, W C Hop, B Lowenberg, and R Q Hintzen
Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 46 - 50.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M P J Garssen, P I M Schmitz, I S J Merkies, B C Jacobs, F G A van der Meche, and P A van Doorn
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial
J. Neurol. Neurosurg. Psychiatry, January 1, 2006; 77(1): 61 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D Buljevac, G J J van Doornum, H Z Flach, J Groen, A D M E Osterhaus, W Hop, P A van Doorn, F G A van der Meche, and R Q Hintzen
Epstein-Barr virus and disease activity in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1377 - 1381.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Nogai, V. Siffrin, K. Bonhagen, C. F. Pfueller, T. Hohnstein, R. Volkmer-Engert, W. Bruck, C. Stadelmann, and T. Kamradt
Lipopolysaccharide Injection Induces Relapses of Experimental Autoimmune Encephalomyelitis in Nontransgenic Mice via Bystander Activation of Autoreactive CD4+ Cells
J. Immunol., July 15, 2005; 175(2): 959 - 966.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S M Leary, B Porter, and A J Thompson
Multiple sclerosis: diagnosis and the management of acute relapses
Postgrad. Med. J., May 1, 2005; 81(955): 302 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Mult SclerHome page
J. D Kriesel and W. A Sibley
The case for rhinoviruses in the pathogenesis of multiple sclerosis
Multiple Sclerosis, February 1, 2005; 11(1): 1 - 4.
[PDF]

Home page
 J. Immunol.Home page
L. Visser, H. Jan de Heer, L. A. Boven, D. van Riel, M. van Meurs, M.-J. Melief, U. Zahringer, J. van Strijp, B. N. Lambrecht, E. E. Nieuwenhuis, et al.
Proinflammatory Bacterial Peptidoglycan as a Cofactor for the Development of Central Nervous System Autoimmune Disease
J. Immunol., January 15, 2005; 174(2): 808 - 816.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Ebringer, L. Hughes, T. Rashid, and C. Wilson
Acinetobacter Immune Responses in Multiple Sclerosis: Etiopathogenetic Role and Its Possible Use as a Diagnostic Marker
Arch Neurol, January 1, 2005; 62(1): 33 - 36.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. M. Kerfoot, E. M. Long, M. J. Hickey, G. Andonegui, B. M. Lapointe, R. C. O. Zanardo, C. Bonder, W. G. James, S. M. Robbins, and P. Kubes
TLR4 Contributes to Disease-Inducing Mechanisms Resulting in Central Nervous System Autoimmune Disease
J. Immunol., December 1, 2004; 173(11): 7070 - 7077.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Bielekova, N. Richert, T. Howard, G. Blevins, S. Markovic-Plese, J. McCartin, J. Wurfel, J. Ohayon, T. A. Waldmann, H. F. McFarland, et al.
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon {beta}
PNAS, June 8, 2004; 101(23): 8705 - 8708.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D.-A. Laplaud, C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al.
Blood T-cell receptor {beta} chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Brain, May 1, 2004; 127(5): 981 - 995.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
D Buljevac, W C J Hop, W Reedeker, A C J W Janssens, F G A van der Meche, P A van Doorn, and R Q Hintzen
Self reported stressful life events and exacerbations in multiple sclerosis: prospective study
BMJ, September 20, 2003; 327(7416): 646.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
C. Du, S.-Y. Yao, A. Ljunggren-Rose, and S. Sriram
Chlamydia pneumoniae Infection of the Central Nervous System Worsens Experimental Allergic Encephalitis
J. Exp. Med., December 16, 2002; 196(12): 1639 - 1644.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. T. Ichikawa, L. P. Williams, and B. M. Segal
Activation of APCs Through CD40 or Toll-Like Receptor 9 Overcomes Tolerance and Precipitates Autoimmune Disease
J. Immunol., September 1, 2002; 169(5): 2781 - 2787.
[Abstract] [Full Text] [PDF]

Home page
 JWatch NeurologyHome page
MS Exacerbations and Infection: Few New Answers
Journal Watch Neurology, June 7, 2002; 2002(607): 3 - 3.
[Full Text]

Home page
 BrainHome page
C. Confavreux
Infections and the risk of relapse in multiple sclerosis
Brain, May 1, 2002; 125(5): 933 - 934.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.